Request a Proposal
Welcome to Rapport, containing tips, truths, news and views, blogs, tweets, articles and films covering a range of topics currently affecting Research Partnership and the pharma market research world
  • Posted by Helen Parfitt
  • November 17, 2020
  • News

Therapy Watch launches a new global Lupus tracker

Therapy Watch launches a new global Lupus tracker

This multi country study will report on patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN) across core global markets.

Lupus is an almost invisible disease, yet can have considerable impact on a person’s quality of life, and there is much that pharma can do to help. The reasons for this autoimmune malfunction remain elusive, although genetic and environmental factors may play a part. Prevalence has been estimated at around 2-140 per 100,000 population worldwide, although it could be as high as 207 per 100,000. Women of childbearing age are around nine times more likely to have lupus than men of equivalent age.

This tracker will help our clients address such questions as understanding the dynamics of the market, including initiation and maintenance therapy choice, drivers for prescribing, patient demographics, market shares, treatment patterns and source of business.

Therapy Watch is a syndicated market tracking tool that provides marketing teams, brand managers and market researchers with strategic and tactical market information. Run entirely online to ensure speed, quality and up-to-date access to the very latest market data,
Therapy Watch offers a clear advantage by putting you in closer contact with your market than ever before.

Watch our video in which Director, Helen Parfitt explains the benefits of Therapy Watch »
Request a telephone call / meeting to discuss Therapy Watch Lupus in more detail »

Sign up to receive Rapport 
Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research. Sign up here » 

comments powered by Disqus